Tracked deals
4
4 tracked deals across 2023-2026.
Public Company
Healthcare
Agilent Technologies
Santa Clara, California, United States
Agilent provides analytical and diagnostic technologies, instruments, software, services, and lab consumables for customers who advance cancer treatment, ensure quality and safety of food, water, air, and medicine, discover new drugs, research infectious diseases, and develop alternative energy solutions.
- Focus Areas
- Analytical instrumentation, Clinical laboratory diagnostics, Laboratory software and services
- Website
- www.agilent.com
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout
Agilent Technologies Acquisition Volume by Year
Last 3 years
Actual
Full-year estimate
Supporting Data
Recent Transactions
-
October 14, 2026
- Buyer
- Agilent Technologies
- Target
- Proscia
- Industry
- Software
- Location
- Pennsylvania, United States
- Type
- Buyout
Agilent Technologies agreed to acquire digital pathology software provider Proscia in an all-cash transaction valued at $240 million at closing, plus up to $30 million tied to future performance milestones. The acquisition is expected to close early in Agilent’s fiscal year 2027 and is intended to expand its pathology software capabilities and support AI-enabled clinical diagnostics and biopharma research.
-
March 9, 2026
- Buyer
- Agilent Technologies Inc.
- Target
- Biocare Medical
- Seller
- Investor group led by Excellere Partners, GHO Capital Partners LLP
- Industry
- Medical Devices
- Location
- California, United States
- Type
- Buyout
Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, for $950 million in an all-cash transaction. The acquisition expands Agilent’s pathology portfolio—particularly in immunohistochemistry (IHC)—and is expected to be accretive to Agilent’s top-line growth rate, margin profile, and non-instrument revenue mix in Year 1.
-
July 22, 2024
- Buyer
- Agilent Technologies Inc.
- Target
- BIOVECTRA Inc.
- Seller
- H.I.G. Capital
- Industry
- Pharmaceuticals
- Location
- Prince Edward Island, Canada
- Type
- Buyout
Agilent Technologies has acquired BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO), for $925 million. The acquisition — a purchase from H.I.G. Capital — expands Agilent's CDMO capabilities across biologics, HPAPIs, pDNA/mRNA and LNP formulation, and integrates BIOVECTRA into Agilent's Diagnostics and Genomics Group.
-
January 4, 2023
- Buyer
- Agilent Technologies Inc.
- Target
- Avida Biomed
- Industry
- Biotechnology
- Location
- California, United States
- Type
- Buyout
Agilent Technologies has acquired Avida Biomed, an early-stage developer of high-performance NGS target enrichment workflows for cancer research. The acquisition augments Agilent's SureSelect portfolio and expands its capabilities into high-growth clinical research and diagnostics markets by adding Avida's chemistries and automatable assays compatible with Agilent platforms.
Related Acquisition Pages
Biotechnology Buyers & Acquisitions
1 tracked deal by Agilent Technologies.
Medical Devices Buyers & Acquisitions
1 tracked deal by Agilent Technologies.
Pharmaceuticals Buyers & Acquisitions
1 tracked deal by Agilent Technologies.
Software Buyers & Acquisitions
1 tracked deal by Agilent Technologies.
Acquisitions in California
2 tracked deals by Agilent Technologies.
Acquisitions in Pennsylvania
1 tracked deal by Agilent Technologies.
Selling a company? Get in front of buyers like Agilent Technologies
Turn tracked acquisition activity into an outreach-ready buyer list.